A New Noncanonical Anionic Peptide That Translocates a Cellular Blood–Brain Barrier Model

The capacity to transport therapeutic molecules across the blood–brain barrier (BBB) represents a breakthrough in the development of tools for the treatment of many central nervous system (CNS)-associated diseases. The BBB, while being protective against infectious agents, hinders the brain uptake o...

Descripción completa

Detalles Bibliográficos
Autores principales: Neves-Coelho, Sara, Eleutério, Rute P., Enguita, Francisco J., Neves, Vera, Castanho, Miguel A. R. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151732/
https://www.ncbi.nlm.nih.gov/pubmed/29057814
http://dx.doi.org/10.3390/molecules22101753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151732/
https://www.ncbi.nlm.nih.gov/pubmed/29057814
http://dx.doi.org/10.3390/molecules22101753

Ejemplares similares